Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SAVA |
---|---|---|
09:32 ET | 4526 | 28.5657 |
09:34 ET | 7300 | 28.615 |
09:36 ET | 553 | 28.615 |
09:38 ET | 35989 | 28.565 |
09:39 ET | 1585 | 28.5983 |
09:41 ET | 1307 | 28.3601 |
09:43 ET | 400 | 28.47 |
09:45 ET | 230 | 28.47 |
09:48 ET | 2600 | 28.53 |
09:50 ET | 1350 | 28.4302 |
09:54 ET | 1629 | 28.53 |
09:56 ET | 3459 | 28.35 |
09:57 ET | 1200 | 28.34 |
09:59 ET | 900 | 28.35 |
10:01 ET | 100 | 28.35 |
10:03 ET | 2923 | 28.49 |
10:06 ET | 5593 | 28.53 |
10:08 ET | 26094 | 28.95 |
10:10 ET | 10839 | 28.9 |
10:12 ET | 20802 | 28.99 |
10:14 ET | 22191 | 29.075 |
10:15 ET | 20820 | 29.0424 |
10:17 ET | 25931 | 29.1984 |
10:19 ET | 9703 | 29.0893 |
10:21 ET | 13718 | 29.1518 |
10:24 ET | 16407 | 29.3499 |
10:26 ET | 3572 | 29.26 |
10:28 ET | 3169 | 29.21 |
10:30 ET | 3568 | 29.24 |
10:32 ET | 4870 | 29.0075 |
10:33 ET | 4650 | 29.1869 |
10:35 ET | 3792 | 29.2 |
10:37 ET | 1300 | 29.05 |
10:39 ET | 3200 | 29.24 |
10:42 ET | 600 | 29.19 |
10:44 ET | 14662 | 29.19 |
10:46 ET | 621 | 29.175 |
10:48 ET | 3822 | 29.11 |
10:50 ET | 4654 | 28.9999 |
10:51 ET | 4349 | 28.86 |
10:53 ET | 1650 | 29.0999 |
10:55 ET | 2846 | 28.93 |
10:57 ET | 1023 | 28.9301 |
11:00 ET | 1608 | 28.96 |
11:02 ET | 4930 | 28.955 |
11:06 ET | 1500 | 29.06 |
11:08 ET | 3085 | 29.15 |
11:09 ET | 47738 | 29.3423 |
11:11 ET | 14013 | 29.4502 |
11:13 ET | 1877 | 29.2999 |
11:15 ET | 1490 | 29.34 |
11:18 ET | 1077 | 29.3 |
11:20 ET | 5792 | 29.19 |
11:22 ET | 3547 | 29.19 |
11:24 ET | 1999 | 29.175 |
11:26 ET | 1400 | 29.2 |
11:27 ET | 200 | 29.2 |
11:29 ET | 1388 | 29.235 |
11:31 ET | 1875 | 29.3 |
11:33 ET | 1800 | 29.3053 |
11:36 ET | 600 | 29.3448 |
11:38 ET | 8558 | 29.22 |
11:40 ET | 1900 | 29.26 |
11:42 ET | 400 | 29.31 |
11:44 ET | 1153 | 29.26 |
11:45 ET | 1091 | 29.3772 |
11:47 ET | 1996 | 29.3 |
11:49 ET | 1364 | 29.27 |
11:54 ET | 100 | 29.304 |
11:56 ET | 7699 | 29.21 |
11:58 ET | 541 | 29.255 |
12:00 ET | 3869 | 29.23 |
12:02 ET | 3375 | 29.2 |
12:03 ET | 300 | 29.19 |
12:05 ET | 100 | 29.1601 |
12:07 ET | 2887 | 29.15 |
12:09 ET | 2117 | 29.1011 |
12:12 ET | 270 | 29.2099 |
12:16 ET | 1390 | 29.13 |
12:18 ET | 1272 | 29.1 |
12:20 ET | 1300 | 29.01 |
12:21 ET | 969 | 29.1399 |
12:23 ET | 14685 | 29.04 |
12:25 ET | 4029 | 28.88 |
12:27 ET | 12222 | 29.12 |
12:30 ET | 2165 | 29.16 |
12:32 ET | 1232 | 29.1758 |
12:34 ET | 300 | 29.1 |
12:38 ET | 1013 | 29.2043 |
12:39 ET | 200 | 29.155 |
12:41 ET | 671 | 29.18 |
12:43 ET | 1123 | 29.186 |
12:45 ET | 800 | 29.1016 |
12:48 ET | 600 | 29.08 |
12:50 ET | 1607 | 28.98 |
12:52 ET | 1000 | 28.89 |
12:54 ET | 1400 | 28.9596 |
12:56 ET | 700 | 28.97 |
12:57 ET | 1018 | 28.97 |
01:01 ET | 1018 | 28.9891 |
01:03 ET | 4931 | 29.02 |
01:06 ET | 200 | 29.03 |
01:08 ET | 600 | 29.035 |
01:10 ET | 500 | 29.0625 |
01:14 ET | 2067 | 28.95 |
01:15 ET | 786 | 29.01 |
01:17 ET | 300 | 29.06 |
01:19 ET | 3827 | 29.08 |
01:21 ET | 100 | 29.18 |
01:24 ET | 200 | 29.22 |
01:26 ET | 1200 | 29.255 |
01:28 ET | 4525 | 29.29 |
01:30 ET | 9368 | 29.27 |
01:32 ET | 13815 | 29.53 |
01:33 ET | 3215 | 29.48 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Cassava Sciences Inc | 1.4B | -72.7x | --- |
Disc Medicine Inc | 1.4B | -13.1x | --- |
ARS Pharmaceuticals Inc | 1.3B | -27.5x | --- |
Spyre Therapeutics Inc | 1.5B | -1.9x | --- |
Pharvaris NV | 1.1B | -7.7x | --- |
Belite Bio Inc | 1.5B | -39.6x | --- |
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. It is conducting two randomized placebo-controlled Phase III clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. SavaDx, its lead investigational diagnostic product candidate, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. SavaDx is a research-use only, non-safety related exploratory biomarker.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.60 |
EPS | $-0.41 |
Book Value | $3.25 |
P/E Ratio | -72.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.